Human interleukin-2 receptor α deficiency

被引:1
|
作者
Roifman, CM
Dadi, HK
机构
[1] Univ Toronto, Div Immunol & Allergy, Dept Paediat, Infect Immun Injury & Repair Program,Res Inst, Toronto, ON M5G 1X8, Canada
[2] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
关键词
D O I
10.1016/S0889-8561(05)70132-6
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Profound cellular immunodeficiency occurs because of mutations in proteins involved in the differentiation and function of mature lymphoid cells. This article describes a novel human immune aberration arising from a truncation mutation of the IL-2 receptor alpha (IL-2R alpha) chain (CD25), a subunit of the tripartite high-affinity receptor for IL-2. Decreased numbers of peripheral T cells displaying abnormal proliferation but normal B-cell development characterize this immunodeficiency. Extensive lymphocytic infiltration of tissues, including lung, liver, gut, and bone, is observed, accompanied by tissue atrophy and inflammation. Although mature T cells are present, the absence of CD25 does affect the differentiation of thymocytes. While displaying normal development of CD2, CD3, CD4, and CD8 expression, CD25-deficient cortical thymocytes do not express CD1; they fail to down-regulate levels of bcl-2 and, subsequently, apoptosis in the thymus is reduced markedly.
引用
收藏
页码:39 / +
页数:13
相关论文
共 50 条
  • [31] INVIVO ADMINISTRATION OF PURIFIED HUMAN INTERLEUKIN-2 TO PATIENTS WITH CANCER - DEVELOPMENT OF INTERLEUKIN-2 RECEPTOR POSITIVE CELLS AND CIRCULATING SOLUBLE INTERLEUKIN-2 RECEPTORS FOLLOWING INTERLEUKIN-2 ADMINISTRATION
    LOTZE, MT
    CUSTER, MC
    SHARROW, SO
    RUBIN, LA
    NELSON, DL
    ROSENBERG, SA
    CANCER RESEARCH, 1987, 47 (08) : 2188 - 2195
  • [32] HUMAN INTERLEUKIN-2
    CHOUAIB, S
    FRADELIZI, D
    ANNALES D IMMUNOLOGIE, 1983, D134 (02): : 157 - 165
  • [33] HUMAN INTERLEUKIN-2
    MERTELSMANN, R
    WELTE, K
    CLINICS IN IMMUNOLOGY AND ALLERGY, 1984, 4 (02): : 393 - 413
  • [34] TRANSMEMBRANE SIGNALING OF INTERLEUKIN-2 RECEPTOR - CONFORMATION AND FUNCTION OF HUMAN INTERLEUKIN-2 RECEPTOR (P55)/INSULIN RECEPTOR CHIMERIC MOLECULES
    HATAKEYAMA, M
    DOI, T
    KONO, T
    MARUYAMA, M
    MINAMOTO, S
    MORI, H
    KOBAYASHI, M
    UCHIYAMA, T
    TANIGUCHI, T
    JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (02): : 362 - 375
  • [35] HUMAN INTERLEUKIN-2
    ROBB, RJ
    METHODS IN ENZYMOLOGY, 1985, 116 : 493 - 525
  • [36] INHIBITION OF INTERLEUKIN-2 PRODUCTION AND EXPRESSION OF THE INTERLEUKIN-2 RECEPTOR BY PLASMA FROM ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME PATIENTS
    FARMER, JL
    GOTTLIEB, AA
    NISHIHARA, T
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1986, 38 (02): : 235 - 243
  • [37] DEFICIENCY OF INTERLEUKIN-2 PRODUCTION AND INTERLEUKIN-2 RECEPTOR EXPRESSION ON PERIPHERAL-BLOOD LEUKOCYTES AFTER PHYTOHEMAGGLUTININ STIMULATION IN PEMPHIGUS
    KERMANIARAB, V
    HIRJI, K
    AHMED, AR
    FAHEY, JL
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1984, 83 (02) : 101 - 104
  • [38] INTERLEUKIN-2 RECEPTOR EXPRESSION AND INTERLEUKIN-2 PRODUCTION IN BULLOUS PEMPHIGOID
    SCHALLER, J
    GIESE, T
    LADUSCH, M
    HAUSTEIN, UF
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1990, 282 (04) : 223 - 226
  • [39] BIOTINYLATED RECOMBINANT INTERLEUKIN-2 - A TOOL FOR RESEARCH ON THE INTERLEUKIN-2 RECEPTOR
    FOXWELL, BMJ
    TAYLOR, D
    GREINER, B
    MIHATSCH, MJ
    OLIVIERI, V
    RYFFEL, B
    JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 113 (02) : 221 - 229
  • [40] DEFICIENCY OF INTERLEUKIN-2 IN PEMPHIGUS VULGARIS
    BLITSTEINWILLINGER, E
    STUTTGEN, G
    ZEITSCHRIFT FUR HAUTKRANKHEITEN H&G, 1986, 61 (1-2): : 82 - 85